Search

everythinglearnresearchcommunity

for

Search:↓

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

Overexpressing PKCα in mice skin increases inflammation but doesn't affect tumor growth.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

The Wave complex controls skin growth by suppressing certain signals.

LTBP1 is a key regulator in diseases and a potential target for new treatments.

LLPS is crucial for RALF signaling, aiding plant growth and stress resilience.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

SP1 promotes and KROX20 inhibits hair cell growth by affecting the CUX1 gene.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

Mutations in β1 integrins cause embryonic death but have milder effects on skin.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Activating c-Myc in skin causes rapid cell growth and changes, but these effects are reversible.

Targeting mitophagy may help treat alopecia areata by reducing inflammasome activation.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

GPRC5D is linked to the formation of hair, nails, and certain tongue areas.

Giving a special protein to dogs with a certain genetic disease improved their symptoms but didn't help with hair growth.

TRPV3 channels are involved in skin processes and are affected by shear stress, influencing itch and mechanotransduction.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

LED light helps human hair root cells grow and move by activating certain cell pathways.

AGD1 is important for root hair development in Arabidopsis, working with phosphoinositide signaling and the actin cytoskeleton.

Acupuncture and moxibustion therapy boost hair growth by enhancing growth factors and enzymes.